Hierabio
The startup develops a stem cell therapy that utilizes organ-intrinsic stem cell separation technology to achieve high-purity cell separation without enzymatic disassembly of organ tissue. This approach aims to enhance regenerative treatment options for patients with intractable diseases by promoting self-replication of living cells.
Traction –/10
Seoul, South Korea · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a stem cell therapy that utilizes organ-intrinsic stem cell separation technology to achieve high-purity cell separation without enzymatic disassembly of organ tissue. This approach aims to enhance regenerative treatment options for patients with intractable diseases by promoting self-replication of living cells.